ÂÜÀòÂÒÂ×

Jonathan Lanfear has served on Molecular Templates’ Board of Directors since May 2018. Mr. Lanfear is currently Principal at Lanfear Advisors LLC, focusing on business development, corporate strategy and operational consulting for public and private biotechnology and biopharmaceutical companies. Previously, Mr. Lanfear was the Vice President and Global Head of R&D Business Development (BD) at Takeda Pharmaceuticals, from 2011 until September 2020, where he oversaw BD activities across Oncology, Neuroscience, Gastroenterology, and Rare Disease Therapeutic Areas. Before joining Takeda in 2011, Mr. Lanfear spent approximately 8 years at Pfizer Inc. as a Senior Director and Transactions Lead in the Worldwide Business Development, Strategy, & Innovation group. Mr. Lanfear also has previous experience in biotechnology equity research, from his time at AG Edwards/Wachovia and in business development, while at Searle/Pharmacia, where he worked on several significant licensing transactions prior to the company’s acquisition. Mr. Lanfear holds a Bachelor of Science in Chemical Engineering and a Master’s degree in Bioengineering, both from the University of Michigan (Ann Arbor), and a Master of Business Administration from Washington University (St. Louis)